Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dendritic Cell Vaccine with Trastuzumab and Vinorelbine in Metastatic Breast Cancer
NCT00088985Phase 2Terminated
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Start
- Jan 2004
- Primary completion
- Oct 2009
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of multiepitope autologous dendritic cell vaccine in breast cancer, sponsored by UNC Lineberger Comprehensive Cancer Center. Started Jan 2004; status: terminated.
02
Drugs
multiepitope autologous dendritic cell vaccine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00088985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00088985.